Ipca Labs Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,131.00
842.00
745.00
1,135.00
1,388.00
738.00
Adjustment
727.00
489.00
235.00
195.00
183.00
247.00
Changes In working Capital
-176.00
-91.00
48.00
-272.00
-236.00
-263.00
Cash Flow after changes in Working Capital
1,682.00
1,240.00
1,029.00
1,058.00
1,335.00
722.00
Cash Flow from Operating Activities
1,321.00
944.00
805.00
856.00
1,090.00
570.00
Cash Flow from Investing Activities
-869.00
-1,215.00
-725.00
-850.00
-520.00
-509.00
Cash Flow from Financing Activities
-282.00
-552.00
507.00
426.00
-305.00
-136.00
Net Cash Inflow / Outflow
168.00
-823.00
588.00
431.00
263.00
-75.00
Opening Cash & Cash Equivalents
755.00
1,578.00
990.00
559.00
295.00
370.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
924.00
755.00
1,578.00
990.00
559.00
295.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Ipca Labs
Figures in Cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
1131.14
656.87
475.00
72.20%
Adjustment
727.89
72.84
655.00
899.30%
Changes In working Capital
-176.46
-152.37
-24.00
-15.81%
Cash Flow after changes in Working Capital
1682.57
577.34
1,105.00
191.43%
Cash Flow from Operating Activities
1321.32
418.34
903.00
215.85%
Cash Flow from Investing Activities
-869.5
-152.11
-717.00
-471.63%
Cash Flow from Financing Activities
-282.98
-133.6
-149.00
-111.81%
Net Cash Inflow / Outflow
168.84
132.62
36.00
27.31%
Opening Cash & Cash Equivalents
755.79
184.36
571.00
309.95%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
924.63
316.98
608.00
191.70%
Cash Flow - Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 39.87% vs 17.23% in Mar 2024
Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
1,321.32
944.65
39.87%






